Abbott (NYSE:ABT) today announced new clinical data highlighting the importance of managing diabetic ketoacidosis (DKA).
Not all patients in the emergency department diagnosed with diabetic ketoacidosis meet laboratory criteria; a study shows that physicians rely on clinical signs and symptoms.
More than a decade ago, researchers found that an acute complication of type 1 diabetes, diabetic ketoacidosis (DKA), can be resolved with the hormone leptin, even in the absence of insulin. An ...
Retrospective cohort study comparing natural history and response to treatment for 37 episodes of SGLT2i-associated DKA (n = 27) or ketosis (n = 10) in people with T2D vs 19 episodes of T1D-associated ...
The world's first dual continuous glucose and ketone monitor is designed to help prevent diabetic ketoacidosis (DKA).
Many children who develop type 1 diabetes, the inability to produce insulin and process blood sugar, do not know they have the condition until symptoms arise. These symptoms are often driven by a ...
Please provide your email address to receive an email when new articles are posted on . Adults with diabetes hospitalized with DKA recurrence have a higher risk for mortality. Providers should closely ...
Diabetic ketoacidosis adverse outcomes were linked to high BUN levels, maximum blood glucose, sodium abnormalities, and a type 2 diabetes diagnosis among children. Maximum blood glucose, blood urea ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results